ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Bill Nearly Became Law Without Nixon’s Signature as Impeachment Obsesses White House

August 2, 1974

Nimer to Lead Miami Sylvester Cancer Center

March 9, 2012

In Brief: NCFA Offers Grants For Research On Impact Of DRGs; ACCC Leaders Dispute HCFA Chief

March 8, 1985

Diet/Nutrition Advisory Group Blast Fund Limit, Incurs Schmidt Wrath

February 4, 1977

Mandates Not welcome In Steady State Funding, Varmus Tells Senate

March 15, 1996

Brenner To Leave Breast Cancer Action

September 17, 2010